Lactobacilli are naturally found in the gastrointestinal tract of chickens, and there is interest in utilizing autochthonous strains for the delivery of therapeutic proteins. Previously we identified three chicken-derived Lactobacillus strains, Lactobacillus agilis La3, Lactobacillus vaginalis Lv5, and Lactobacillus crispatus Lc9, which persist in the gastrointestinal tract of chickens fed either a commercial or high-protein diet. In the current study, we investigated the ability to electrotransform these strains, determined plasmid vector stability, and compared reporter gene expression directed by several different promoters. The La3 and Lv5 strains were reproducibly transformed with efficiencies of 10 8 and 10 6 transformants per microgram of plasmid DNA, respectively. The third strain tested, L. crispatus Lc9, was recalcitrant to all transformation protocols examined. The plasmid vectors pTRK563 and pTRKH2 were maintained over 100 generations in La3 and Lv5, respectively. The ability of La3 and Lv5 to express the heterologous reporter gene gfp was analyzed using heterologous and homologous promoters. Transformants of both La3 and Lv5 containing the La3 ldhL promoter were the most fluorescent. To our knowledge, this is the first report of successful transformation and heterologous protein expression in L. agilis and L. vaginalis. The ability of these strains to express heterologous proteins in vitro indicates their potential utility as in vivo delivery vectors for therapeutic peptides to the chicken gastrointestinal tract.Lactobacilli are autochthonous inhabitants of the chicken gastrointestinal tract (GIT), where they predominate the upper GIT microbiota (53). Their dominance of the upper GIT makes lactobacilli excellent candidates for development as live vectors for the delivery of therapeutic proteins targeting bacterial pathogens such as Clostridium perfringens, Campylobacter jejuni, Listeria monocytogenes, or Salmonella enterica. Additionally, lactobacillus delivery vectors could be used to immunize against avian viruses, such as infectious bursal disease, Marek's disease, Newcastle disease, or avian influenza virus. We have recently identified several Lactobacillus strains, Lactobacillus agilis La3, Lactobacillus vaginalis Lv5, and Lactobacillus crispatus Lc9, which are able to colonize and persist within the GIT of chickens fed either a commercial or a highprotein diet (45). These strains show great potential as vectors for the in situ delivery of therapeutic proteins targeting GIT pathogens.Lactobacilli have several advantages as mucosal delivery vectors (54), including "generally regarded as safe" status, survival within the GIT, stimulation of immune responses in the mucosa, and the potential to be engineered to express therapeutic peptides. In regard to the latter, lactobacilli are notoriously recalcitrant to transformation, representing an important limitation in realizing the vectoring potential of persistent strains.Several studies have investigated the genetic transformation of chicken Lactobac...